EBOS GROUP LIMITED — M&A Activity 2017

May 22, 2017

NZX/ASX Code: EBO

23 May 2017

==> picture [149 x 44] intentionally omitted <==

EBOS ENTERS AGREEMENT TO ACQUIRE HPS

EBOS is pleased to announce that it has entered into a binding agreement to acquire HPS, Australia’s largest provider of outsourced pharmacy services to hospitals, for a purchase price of A$154 million. This acquisition both complements and extends EBOS’ existing Australian hospital business and provides a new platform for expansion in this important market.

HPS (www.hps.com.au) has long term relationships and contracts with a number of key private hospital groups, correctional facilities, oncology and fertility clinics. HPS has grown strongly in recent years and its business model is underpinned by solid demand for outsourced pharmacy services. HPS has over 40 years’ experience in the provision of services to health facilities, offering tailored and responsive services which ultimately contribute to the delivery of individualised patient care.

EBOS Group Chief Executive Officer, Patrick Davies said the acquisition of HPS is an important strategic investment as it provides the Group with a vertically integrated model in a market segment that has attractive long term growth prospects, including the continued introduction of new drugs.

“The acquisition of HPS continues EBOS’ history of expansion in both the Australian and New Zealand hospital markets where it is the leading provider of wholesale pharmaceutical services. By virtue of this acquisition, EBOS will be the leading provider of outsourced pharmacy services in the Australian hospital sector.” Mr Davies said.

“We are confident we can continue to support the growth of HPS and we are delighted to have reached agreement to acquire this high quality business. This transaction is part of our ongoing strategic expansion and diversification into areas where we believe there are attractive long term opportunities for our Group.“

The key management of HPS will continue to operate the business under EBOS’ ownership and will form part of EBOS Group’s Institutional Healthcare business division.

HPS services over 100 sites and employs over 580 staff including over 200 pharmacists.

The acquisition of HPS is expected to increase EBOS Group’s underlying EBITDA by at least 5% in FY18 and will be EPS accretive from year 1.

The acquisition will be fully debt financed.

The agreement to acquire HPS includes certain conditions. The transaction is expected to complete by no later than 30 June 2017.

For further information, please contact:

Media: Investor Relations: Patrick Davies Mark Connell CEO EBOS Group Investor Relations Manager, EBOS Group +613 9918 5555 +61 402 995 519

About EBOS Group

EBOS Group Limited NZBN 9429031998840 (NZX/ASX Code: EBO) is the largest and most diversified Australasian marketer, wholesaler and distributor of healthcare, medical and pharmaceutical products. It is also a leading Australasian animal care products marketer and distributor.

EBOS Group Limited. NZBN 9429031998840 Level 7, 737 Bourke Street, Docklands, Victoria 3008, Australia. PO Box 7300, Melbourne, Victoria 8004, Australia. Phone: +61 3 9918 5555, Fax: +61 3 9918 5588.

www.ebos.co.nz